Fremanezumab in the treatment of migraines: evidence to date

Jennifer Robblee, Juliana VanderPluymDepartment of Neurology, Mayo Clinic, Scottsdale, AZ, USACorrespondence: Juliana VanderPluymDepartment of Neurology, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ 85259, USAEmail vanderpluym.juliana@mayo.eduAbstract: Calcitonin gene-related peptide (CGRP) is a m...

Full description

Bibliographic Details
Published in:Journal of Pain Research
Main Authors: Robblee J, VanderPluym J
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Subjects:
fremanezumab
migraine
headache
calcitonin gene-related peptide (CGRP)
treatment
monoclonal antibody
Online Access:https://www.dovepress.com/fremanezumab-in-the-treatment-of-migraines-evidence-to-date-peer-reviewed-article-JPR

Internet

https://www.dovepress.com/fremanezumab-in-the-treatment-of-migraines-evidence-to-date-peer-reviewed-article-JPR

Similar Items